Senseonics Holdings (SENS) Asset Writedowns and Impairment (2017 - 2026)
Senseonics Holdings' (SENS) quarterly Asset Writedowns and Impairment came in at -$345000.0 in Q1 2026, down 334.69% year-on-year from $147000.0 in Q1 2025, and down 169.84% on a QoQ basis from $494000.0 in Q4 2025.
Senseonics Holdings (SENS) Asset Writedowns and Impairment (2017 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has 9 years of Asset Writedowns and Impairment data on file, last reported at -$345000.0 in Q1 2026.
- On a quarterly basis, Asset Writedowns and Impairment fell 334.69% year-over-year to -$345000.0 in Q1 2026; TTM through Mar 2026 was $202000.0, a 38.23% decrease from a year earlier, with the FY2025 full-year figure at $694000.0, up 215.45% from the prior year.
- Asset Writedowns and Impairment for Q1 2026 stood at -$345000.0, down from $494000.0 in the prior quarter.
- Over the last five years, Asset Writedowns and Impairment for SENS reached as high as $4.2 million in Q3 2024 and fell as low as -$4.0 million in Q4 2024.
- Historically, Asset Writedowns and Impairment has averaged $57153.8 across 4 years, with a median of $40000.0 in 2024.
- On a YoY basis, Asset Writedowns and Impairment climbed as much as 2595.45% in 2024 and fell as far as 4785.88% in 2024.
- Year by year, Asset Writedowns and Impairment stood at $85000.0 in 2023, then sank by 4785.88% to -$4.0 million in 2024, then jumped by 112.4% to $494000.0 in 2025, then slumped by 169.84% to -$345000.0 in 2026.
- Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were -$345000.0 in Q1 2026, $494000.0 in Q4 2025, and $46000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn |
| 2 | Stryker | 129.01 Bn | 126.14 Bn | 3.81 Bn |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.40 Bn | 44.73 Bn | 1.29 Bn |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.36 Bn | 26.07 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 25.46 Bn | 22.33 Bn | 2.07 Bn |
| 10 | Senseonics Holdings | 229.57 Mn | 165.25 Mn | 6.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -345,000.00 |
| Mar 31, 2026 | -345,000.00 |
| Dec 31, 2025 | 494,000.00 |
| Dec 31, 2025 | 494,000.00 |
| Sep 30, 2025 | 46,000.00 |
| Sep 30, 2025 | 46,000.00 |
| Jun 30, 2025 | 7,000.00 |
| Jun 30, 2025 | 7,000.00 |
| Mar 31, 2025 | 147,000.00 |
| Mar 31, 2025 | 147,000.00 |
| Dec 31, 2024 | -3.98 Mn |
| Dec 31, 2024 | -3.98 Mn |
| Sep 30, 2024 | 4.15 Mn |
| Sep 30, 2024 | 4.15 Mn |
| Jun 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Dec 31, 2023 | 85,000.00 |
| Dec 31, 2023 | 85,000.00 |